Stockreport

BRIEF-Odonate Therapeutics Announces Initiation Of CONTESSA, A Phase 3 Study Of Tesetaxel In Patients With Locally Advanced Or Metastatic Breast Cancer [Reuters]

Odonate Therapeutics, Inc.  (ODT) 
Last odonate therapeutics, inc. earnings: 4/28 08:15 am Check Earnings Report
US:NASDAQ Investor Relations: ir.odonate.com/contact-ir
PDF BRIEF-Odonate Therapeutics Announces Initiation Of CONTESSA, A Phase 3 Study Of Tesetaxel In Patients With Locally Advanced Or Metastatic Breast Cancer | Reuters Reuters [Read more]